Pharmaceutical composition, methods for treating and uses thereof
AssigneeBoehringer Ingelheim International GmbH
InventorsUli Christian BROEDL, Afshin SALSALI, Hans-Juergen WOERLE
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for preventing or treating acute or chronic heart failure and for reducing the risk of cardiovascular death, hospitalization for heart failure and other conditions in patients with preserved or reduced ejection fraction by administering empagliflozin to the patient.
Claims15
A method for treating, preventing, protecting against or delaying the occurrence of chronic heart failure in a patient in need thereof comprising administering empagliflozin to the patient.
A method for:
- reducing the risk of cardiovascular death;
- reducing the risk of hospitalization for heart failure;
- reducing all-cause mortality;
- reducing the risk of all-cause hospitalization;
- or
- reducing the risk of new onset of atrial fibrillation
- in a patient with chronic heart failure comprising administering empagliflozin to the patient.
A method for treating, preventing, protecting against, reducing the risk of or delaying the occurrence of acute heart failure, including acute decompensated heart failure, in a patient in need thereof comprising administering empagliflozin to the patient.
A method for treating, preventing, protecting against, reducing the risk of, delaying the occurrence of and/or delaying the progression of chronic kidney disease in a patient with chronic heart failure comprising administering empagliflozin to the patient.
A method for improving the health related quality of life and/or the functional capacity in a patient with chronic heart failure comprising administering empagliflozin to the patient.
Dependencies are inferred from the claim text.